Evidence map›Paper›PMID 34713623›Full record

ArticleJournal of the International AIDS Society2021

Evaluation of the integration of telehealth into the same-day antiretroviral therapy initiation service in Bangkok, Thailand in response to COVID-19: a mixed-method analysis of real-world data.

Sorawit Amatavete, Sita Lujintanon, Nipat Teeratakulpisarn, Supanat Thitipatarakorn, Pich Seekaew, Chonticha Hanaree, Jirayuth Sripanjakun, Chotika Prabjuntuek, Lertkwan Suwannarat, Thana Phattanathawornkool and 7 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 2 countries.

Sorawit AmataveteInstitute of HIV Research and Innovation, Bangkok, Thailand.ORCID 0000-0002-1902-4016
Sita LujintanonInstitute of HIV Research and Innovation, Bangkok, Thailand.ORCID 0000-0001-5380-2013
Nipat TeeratakulpisarnInstitute of HIV Research and Innovation, Bangkok, Thailand.
Supanat ThitipatarakornInstitute of HIV Research and Innovation, Bangkok, Thailand.ORCID 0000-0003-3639-549X
Pich SeekaewInstitute of HIV Research and Innovation, Bangkok, Thailand.ORCID 0000-0002-3941-3457
Chonticha HanareeInstitute of HIV Research and Innovation, Bangkok, Thailand.
Jirayuth SripanjakunInstitute of HIV Research and Innovation, Bangkok, Thailand.
Chotika PrabjuntuekInstitute of HIV Research and Innovation, Bangkok, Thailand.
Lertkwan SuwannaratInstitute of HIV Research and Innovation, Bangkok, Thailand.
Thana PhattanathawornkoolInstitute of HIV Research and Innovation, Bangkok, Thailand.
Nuttawoot PhotisanInstitute of HIV Research and Innovation, Bangkok, Thailand.
Sujittra SuriwongInstitute of HIV Research and Innovation, Bangkok, Thailand.
Matthew AveryFHI 360 and LINKAGES, Bangkok, Thailand.
Stephen MillsFHI 360 and LINKAGES, Bangkok, Thailand.ORCID 0000-0001-7326-6342
Praphan PhanuphakInstitute of HIV Research and Innovation, Bangkok, Thailand.
Nittaya PhanuphakInstitute of HIV Research and Innovation, Bangkok, Thailand.ORCID 0000-0002-0036-3165
Reshmie A RamautarsingInstitute of HIV Research and Innovation, Bangkok, Thailand.ORCID 0000-0002-6293-9422
HIV Netherlands Australia Thailand Research Collaboration · THThai-Nichi Institute of Technology · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSame-day antiretroviral therapy (SDART) initiation has been implemented at the Thai Red Cross Anonymous Clinic (TRCAC) in Bangkok, Thailand, since 2017. HIV-positive, antiretroviral therapy (ART)-naïve clients who are willing and clinically eligible start ART on the day of HIV diagnosis. In response to the first wave of the coronavirus disease 2019 (COVID-19) outbreak in March 2020, telehealth follow-up was established to comply with COVID-19 preventive measures and allow service continuation. Here, we evaluate its implementation.

methodsPre-COVID-19 (until February 2020) clients who initiated SDART received a 2-week ART supply and returned to the clinic for evaluation before being referred to long-term ART maintenance facilities. If no adverse events (AEs) occurred, another 8-week ART supply was provided while referral was arranged. During the first wave of COVID-19 (March-May 2020), clients received a 4-week ART supply and the option of conducting follow-up consultation and physical examination via video call. Clients with severe AEs were required to return to TRCAC; those without received another 6-week ART supply by courier to bridge transition to long-term facilities. This adaptation continued post-first wave (May-August 2020). Routine service data were analysed using data from March to August 2019 for the pre-COVID-19 period. Interviews and thematic analysis were conducted to understand experiences of clients and providers, and gain feedback for service improvement.

resultsOf 922, 183 and 321 eligible clients from the three periods, SDART reach [89.9%, 96.2% and 92.2% (p = 0.018)] and ART initiation rates [88.1%, 90.9% and 94.9% (p<0.001)] were high. ART uptake, time to ART initiation and rates of follow-up completion improved over time. After the integration, 35.3% received the telehealth follow-up. The rates of successful referral to a long-term facility (91.8% vs. 95.3%, p = 0.535) and retention in care at months 3 (97.5% vs. 98.0%, p = 0.963) and 6 (94.1% vs. 98.4%, p = 0.148) were comparable for those receiving in-person and telehealth follow-up. Six clients and nine providers were interviewed; six themes on service experience and feedback were identified.

conclusionsTelehealth follow-up with ART delivery for SDART clients is a feasible option to differentiate ART initiation services at TRCAC, which led to its incorporation into routine service.

Indexed as

Anti-HIV AgentsCOVID-19HIV InfectionsTelemedicineHumansSARS-CoV-2ThailandAnti-HIV AgentsAsiadifferentiated careHIVlinkage to care COVID-19same-day antiretroviral therapytelehealth

Identifiers

PMID34713623
PMCPMC8554221
OpenAlexW3208189366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.